Daewoong to co-promote Lundbeck Korea’s Alzheimer’s disease treatment – Korea Biomedical Review

July 12, 2019 by  
Filed under Alzheimers News

Sponsored By

Daewoong to co-promote Lundbeck Korea’s Alzheimer’s disease treatment  Korea Biomedical Review

Daewoong Pharmaceutical said that it has agreed to promote Lundbeck Korea’s Ebixa, an Alzheimer’s disease treatment, jointly with the maker.

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*